Survey of thrombotic microangiopathy within 1 week after kidney transplantation between 2010 and 2015 in Japan

Springer Science and Business Media LLC - Tập 23 - Trang 571-572 - 2018
Shigeru Satoh1, Kazuhide Saito2, Hiroshi Harada3, Masayoshi Okumi4, Mitsuru Saito5
1Center for Kidney Disease and Transplantation, Akita University Hospital, Akita, Japan
2Department of Urology, Niigata University School of Medicine, Niigata, Japan
3Department of Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan
4Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
5Department of Urology, Akita University School of Medicine, Akita, Japan

Tài liệu tham khảo

Noris M, Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Transpl. 2010;10:1517–23. Zuber J, Le Quintrec M, Morris H, Fremeaux-Bacchi V, Loirat C, Legendre C. Targed strategies in the prevention and management of atypical HUS recurrence after kidney transplantation. Transpl Rev (Orland). 2013;27:117–25. Ikeda T, Okumi M, Unagami K, Kanzawa T, Sawada A, Kawanishi K, et al. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab. Nephrology (Carlton). 2016;21(Suppl 1):35–40. Le Quintrec M, Zubar J, Moulin B, Kamar N, Jablonski M, Lionet A, et al. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Am J Transpl. 2013;13:663–75. Nadasdy T. Thrombotic microangiopathy in renal allografts: the diagnostic challenge. Curr Opin Organ Transpl. 2014;19:283–92.